Bluebird Bio Sells to Carlyle, SK Capital

This is a Lyfgenia news story, published by CNBC, that relates primarily to Carlyle news.

Lyfgenia news

For more Lyfgenia news, you can click here:

more Lyfgenia news

Carlyle news

For more Carlyle news, you can click here:

more Carlyle news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Bluebird shares

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest private equity firms Carlyle news, buzziest biotech firms news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Bluebird Bio